Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

593 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Advances in rheumatology: new targeted therapeutics.
Tak PP, Kalden JR. Tak PP, et al. Among authors: kalden jr. Arthritis Res Ther. 2011 May 25;13 Suppl 1(Suppl 1):S5. doi: 10.1186/1478-6354-13-S1-S5. Arthritis Res Ther. 2011. PMID: 21624184 Free PMC article. Review.
Advances in targeted therapies 2017.
Breedveld FC, Kalden JR, Smolen JS. Breedveld FC, et al. Among authors: kalden jr. Clin Immunol. 2018 Jan;186:1-2. doi: 10.1016/j.clim.2018.01.007. Epub 2018 Jan 31. Clin Immunol. 2018. PMID: 29378299 No abstract available.
Perspectives for TNF-alpha-targeting therapies.
Lorenz HM, Kalden JR. Lorenz HM, et al. Among authors: kalden jr. Arthritis Res. 2002;4 Suppl 3(Suppl 3):S17-24. doi: 10.1186/ar564. Epub 2002 May 9. Arthritis Res. 2002. PMID: 12110119 Free PMC article. Review.
Anti-TNF therapy: what have we learned in 12 years?
Kalden JR. Kalden JR. Arthritis Res Ther. 2011 May 25;13 Suppl 1(Suppl 1):S1. doi: 10.1186/1478-6354-13-S1-S1. Arthritis Res Ther. 2011. PMID: 21624180 Free PMC article. No abstract available.
593 results